Results 241 to 250 of about 6,929,915 (302)
Translating culture into design practice: a preliminary test of a dual-cultural framework for animation. [PDF]
Zhang Y, Heo J.
europepmc +1 more source
Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen +19 more
wiley +1 more source
The intermediate hippocampus integrates shock-observation and spatial information during observational fear memory in male rats. [PDF]
Michon Linde F, Gazzola V, Keysers C.
europepmc +1 more source
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani +9 more
wiley +1 more source
Everyday Out-of-Home Activities and Healthy Ageing: A Diary-Based Analysis of Activity Locations, Purposes and Characteristics and Their Relevance to Environmental Design for Ageing-in-Place. [PDF]
Tong K +3 more
europepmc +1 more source
Loss of eIF5A rewires thapsigargin‐mediated endoplasmic reticulum stress responses in multiple myeloma cells by selective translation of mRNA transcripts, consequently dampening thapsigargin‐induced unfolded protein response (UPR) activation and shifting the balance from induction of apoptosis toward cell survival and proliferation.
Demi Both +7 more
wiley +1 more source
MambaAdapt: Joint Descriptor-Alignment Learning with Mamba-Transformer Fusion for Robust Long-Term VPR. [PDF]
Fahad M, He D, Yu W, Truong TK.
europepmc +1 more source
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source

